Of note, subdividing GBM samples into primary and relapsed tumors (1st and 2nd relapse) revealed an elevated expression of PAR1, PAR2 and PAR3 without any significant differences between these tumor specimens (Figure 1B). This evidence concerns the gene F2R and glioblastoma.